EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment
Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) presents a formidable challenge in oncology due to its aggressive nature and resistance to…
Peptide radiopharmaceuticals
Notifications and Health Consequences of Unauthorized Pharmaceuticals in Food Supplements
Abstract Health concerns associated with the consumption of food supplements rise in parallel with the rise in the popularity and…